We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$536M
AUM Growth
+$12.7M
Cap. Flow
-$1.73M
Cap. Flow %
-0.32%
Top 10 Hldgs %
55.09%
Holding
62
New
3
Increased
27
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$5.14M
2
HSY icon
Hershey
HSY
+$2.45M
3
CTVA icon
Corteva
CTVA
+$2.27M
4
WBA
Walgreens Boots Alliance
WBA
+$775K
5
DOW icon
Dow Inc
DOW
+$552K

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$6.98M
2
CSCO icon
Cisco
CSCO
+$4.51M
3
VVV icon
Valvoline
VVV
+$2.33M
4
CHL
China Mobile Limited
CHL
+$1.16M
5
NVS icon
Novartis
NVS
+$789K

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 20.73%
3 Financials 14.14%
4 Industrials 12.91%
5 Consumer Staples 12.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.81T
$41.1M 7.67%
307,097
+4,088
+1% +$519K
MDT icon
2
Medtronic
MDT
$117B
$40.9M 7.62%
419,759
+3,752
+0.9% +$343K
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$38.2M 7.12%
698,064
+14,584
+2% +$775K
JNJ icon
4
Johnson & Johnson
JNJ
$646B
$36.9M 6.87%
264,604
+1,977
+0.8% +$274K
RTX icon
5
RTX Corp
RTX
$285B
$29.5M 5.49%
359,460
+2,184
+0.6% +$183K
AON icon
6
Aon
AON
$75.4B
$24.4M 4.55%
126,297
-7
-0% -$1.27K
AXP icon
7
American Express
AXP
$225B
$23.1M 4.31%
187,315
+2,374
+1% +$279K
MSI icon
8
Motorola Solutions
MSI
$80.4B
$23M 4.29%
138,011
-989
-0.7% -$149K
CSCO icon
9
Cisco
CSCO
$433B
$20.3M 3.78%
370,220
-81,737
-18% -$4.51M
PM icon
10
Philip Morris
PM
$299B
$18.1M 3.37%
230,203
+4,100
+2% +$339K
UNP icon
11
Union Pacific
UNP
$183B
$17.1M 3.2%
101,364
+1,441
+1% +$247K
PEP icon
12
PepsiCo
PEP
$193B
$17M 3.17%
129,600
-54,471
-30% -$6.98M
ORCL icon
13
Oracle
ORCL
$435B
$14.8M 2.75%
259,179
+1,549
+0.6% +$83.8K
VVV icon
14
Valvoline
VVV
$4.1B
$12.6M 2.35%
645,886
-126,073
-16% -$2.33M
UNH icon
15
UnitedHealth
UNH
$353B
$12.4M 2.32%
50,897
-16
-0% -$3.85K
BAX icon
16
Baxter International
BAX
$13.5B
$11.9M 2.23%
145,890
+501
+0.3% +$38.9K
TFC icon
17
Truist Financial
TFC
$61.6B
$11.3M 2.1%
229,654
+3,288
+1% +$161K
WFC icon
18
Wells Fargo
WFC
$262B
$10.6M 1.98%
224,359
+3,160
+1% +$148K
HSY icon
19
Hershey
HSY
$36B
$9.84M 1.84%
73,419
+19,246
+36% +$2.45M
PFE icon
20
Pfizer
PFE
$159B
$9.8M 1.83%
238,417
-584
-0.2% -$23.2K
GNTX icon
21
Gentex
GNTX
$4.78B
$9.31M 1.74%
378,434
+9,671
+3% +$219K
CHRW icon
22
C.H. Robinson
CHRW
$17.6B
$7.68M 1.43%
91,062
+1,269
+1% +$107K
NVS icon
23
Novartis
NVS
$292B
$7.36M 1.37%
80,567
-9,320
-10% -$789K
GWW icon
24
W.W. Grainger
GWW
$61.5B
$5.48M 1.02%
20,421
+63
+0.3% +$17.7K
DD icon
25
DuPont de Nemours
DD
$18.5B
$5.21M 0.97%
55,309
+43,064
+352% +$5.14M

Similar funds

Foyston, Gordon, & Payne's Q2 2019 Portfolio in Review

As of Q2 2019, Foyston, Gordon, & Payne held 62 positions worth $536M, up 2.4% from $523M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Foyston, Gordon, & Payne's Q2 2019 filing shows 3 new, 27 increased, 21 reduced and 2 closed positions. Its largest new stake was Corteva: 84,235 shares worth $2.49M. The largest sale was PepsiCo, an estimated $6.98M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Foyston, Gordon, & Payne's largest Q2 2019 buy was Corteva: 84,235 shares worth $2.49M.
  • Foyston, Gordon, & Payne added most to DuPont de Nemours in Q2 2019, an estimated $5.14M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2019 reduction was PepsiCo, cutting an estimated $6.98M.
  • Foyston, Gordon, & Payne fully exited China Mobile Limited in Q2 2019, selling an estimated $1.16M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 55% of its $536M portfolio in Q2 2019.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 2 in Q2 2019.
  • Foyston, Gordon, & Payne's portfolio value rose 2.4% quarter-over-quarter to $536M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2019, filed 15 Aug 2019.